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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not the
supplementation of N-3 fatty acids containing DHA throughout pregnancy and
breastfeeding improve child cognition.
Study Design: Review of three double blind randomized controlled clinical trials (RCTs)
published in 2003 and 2011.
Data Sources: Three peer-reviewed RCTs were found using PubMed and Medline. These
studies compared DHA supplementation against various placebos.
Outcomes Measured: enhanced child cognition was assessed via various exams,
including the Kaufman Assessment Battery for Children (K-ABC) and Fagan tests.
Significant outcomes were evaluated through the use of SD, Mean Scores, and p-values.
Results: Helland et al (2003) found significant cognitive differences between 4 year old
children born to DHA and non-DHA supplemented mothers, via MPC scores on the KABC test (106.4[7.4] v. 102.3[11.3]; P=0.049). Helland (2001) and Campoy (2011),
however, did not note any significant differences between children on either the Fagan
((55.2[4.5] vs. 55.4[3.7]% at 6 months and 55.5[3.8] vs. 56.2[3.5]% at 9 months) or KABC tests (110[11] vs. 110[14.5] at 6.5 years old) respectively.
Conclusion: Conflicting results from these three RCTs demonstrate that the effects of
supplementing pregnant and breast-feeding mothers with N-3 fatty acids containing DHA
on child cognition is inconclusive.
Key Words: DHA supplementation, Pregnancy, Lactation, Cognition.

Parenti, DHA Supplementation and Cognition 1
	
  
INTRODUCTION
Cognition is a multi-faceted entity formed from various contributing factors, but,
in recent years, the role of Docosahexaenoic acid (DHA) in the developing brain has
become a primary focus. Cognition has often been defined as an avenue for the
processing of information and application of acquired knowledge, encompassing aspects
such as awareness, understanding, learning, perception, reasoning, and judgment. 1,2 In
short, it is an observable outward expression of intelligence. Evidence of this correlation
is seen in both psychometric evidence and brain-imaging studies. “Factor-analytic studies
have demonstrated that measures of working memory (cognition) correlate extremely
highly (r’s >0.90) with the general intelligence factor.” 2 Furthermore, structural MRI’s
have shown similar activations of the pre-frontal cortex and anterior cingulate gyrus
when individuals are taking intelligence exams, such as the Raven’s Progressive Matrices
Test, and during working memory tasks. 2 This paper will evaluate three randomized
controlled trials (RCTs) that sought to compare the cognition of children born to mothers
who did and did not take DHA supplementation throughout pregnancy and breastfeeding
via various intelligence testing.
The relevance of cognition to both patients and healthcare providers alike is
profound. Unlike disease states, which burden varying degrees of the population,
cognition is a part of every individual’s life. In a world that emphasizes the importance
of health, achievement, and success, the possibility of providing one’s unborn child with
an edge in this arena, through the use of prenatal supplementation, will most certainly
bring this issue to nearly every health care provider’s door. It is estimated that up to 95
percent of pregnant mothers take some type of prenatal supplement. On average, the cost
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of taking the recommended supplementations of vitamins A through E, folic acid, iron,
and calcium from three months before pregnancy through a year of breastfeeding totals
nearly $220 per individual.3,4,5 Furthermore, a great number of healthcare visits
accompany the birth process in order to assess fetal development and well being.
Pregnant women are advised to see their obstetrician once each month for weeks 4
through 28, then twice a month for weeks 28 through 36, and weekly from weeks 36 to
birth.6
Cognition is a complex entity with both genetic and environmental components.
Fetal brain development undergoes its most rapid period of growth from the third
trimester through the second year of life. 7 During this critical time, neurologic
development is heavily dependent on the energy it derives from the mother’s diet via
placental transfer and breast milk; long-chain polyunsaturated fatty acids play a
particularly important role. More specifically, it is the N-3 fatty acid, DHA, which makes
up nearly 30% of brain structure and aids in neuronal cell formation and signaling in the
gray matter of the cerebral cortex. 7 DHA also plays a role in the ongoing structure of the
adult brain, where it serves as the most abundant fatty acid in cell membranes, altering
permeability and enhancing protein activity. 7 “Pregnant and lactating women require at
least 300mg of daily DHA intake to promote optimal nervous system development in
their children.”7 By measuring DHA levels in the umbilical artery and vein of infants at
birth, researchers have correlated low concentration levels to neurologic abnormalities
and even stillbirths.8
Cognitive disparities from child to child have prompted the development of
various interventional techniques, such as early brain training programs, remediation
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techniques, and compensatory strategies, to narrow the gap. These strategies, however,
have proven to be of limited value.9 Due to its relative safety, efficacy, tolerability, and
known role in neurologic development, DHA supplementation is now being proposed as
an alternative treatment resource.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not the
supplementation of N-3 fatty acids containing DHA throughout pregnancy and
breastfeeding improves child cognition.
METHODS
Three double blind randomized controlled studies were used in this review. Each
study’s population followed a group of women from pregnancy through lactation, as the
intervention of N-3 fatty acids containing DHA were introduced to the experimental
groups. The specific concentration and source of DHA intake varied across the studies, as
did the structure of each control group; the commonality, however, was the absence of
DHA in whichever prenatal supplement the comparison control group was instructed to
take. After birth, the transfer of DHA from mother to fetus was confirmed by obtaining
levels in either blood, the umbilical cord of infants, or maternal milk. Cognitive function
was then later assessed using various tests, including the Fagan and Kaufman Assessment
Battery for Children (K-ABC).
Key words used in the search included DHA, pregnancy, breastfeeding, and
cognition. The chosen articles were all written in English and published in peer-reviewed
journals between 2003 and 2011. Each was found through the PubMed and Medline
databases, and selected based on its relevance to my initial clinical question and its ability
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to be correlated to the outcome in question. The inclusion criteria consisted of
randomized controlled trials and a population of healthy pregnant women with
uncomplicated singleton pregnancies. Pregnant women who had previously taken any
prenatal supplements before the start of the trial were excluded, as were infants suffering
from premature births, infections, asphyxia, and congenital abnormalities. Summary
statistics were reported using standard deviations, means, medians, and p-values.
Table 1: Demographics & Characteristics of Included Studies
Study

Type

#Pts

Age
(yrs)
1840

Inclusion
Criteria
Healthy
women,
Uncomplicated
Singleton
Pregnancies,
weight: 50-92
kg, intention to
breast feed

Exclusion
Criteria
No prior
supplementation
during
pregnancy,
premature
births,
infections,
asphyxia,
congenital
anomalies

W/D

Interventions

Campoy
et al10
(2011)

Double
Blind,
RCT

270

109

590

1935

Healthy, nulli
or primi
parous women,
singleton
pregnancies,
intention to
breast feed

245

590

1935

Healthy, nulli
or primi
parous women,
singleton
pregnancies,
intention to
breast feed

No prior
supplementation
during
pregnancy,
premature
births,
infections,
asphyxia,
congenital
anomalies
No prior
supplementation
during
pregnancy,
premature
births,
infections,
asphyxia,
congenital
anomalies

N-3 long chain
poly unsaturated
fatty acids
containing
500mg/d DHA
and 0.5% formula
DHA (from the
20th wk of
pregnancy until
birth and from
birth until 6 mo
after delivery,
respectively)
Cod liver oil with
DHA
(1183mg/10mL/d)
from the 17th wk
of pregnancy until
3 mo after
delivery

Helland
et al11
(2001)

Double
Blind,
RCT

Helland
et al12
(2003)

Double
Blind,
RCT

506

Cod liver oil with
DHA
(1183mg/10mL/d)
from the 17th wk
of pregnancy until
3 mo after
delivery
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OUTCOMES MEASURED
Each child, whose mother successfully adhered to all experimental procedures,
was invited to complete either the Fagan or K-ABC test at various ages post-birth. These
tests successfully measure cognition by evaluating a child’s ability to process information
and correlating it to a quantitative exam score.13 In the Fagan Test, this processing is
measured on the theory that an infant tends to “look longer at new targets, such as a
picture of a woman’s face, than at one previously seen.” 13 An infant’s “preference for
novelty” tells us that the infant has the ability to acquire knowledge, process stimuli, and
make discriminations. 13 A specific computer program then derives novelty scores, which
are simply “the amount of fixation devoted to the novel picture divided by the total
fixation time to both the novel and familiar picture, multiplied by 100.” 13 Individual
novelty preference scores are then compared to the mean, where higher scores indicate
higher levels of cognitive function.
The K-ABC test, which is comprised of four scores from sixteen subtests,
including sequential processing, simultaneous processing, achievement, and mental
processing scales, was also used to assess cognition.14 “The sequential processing scale
measures short-term memory and problem solving skills, such as recalling numbers and
arranging items. The simultaneous processing scale examines skills that require a child to
process several stimuli at once, such as facial recognition. These two scores comprise the
mental processing composite (MPC), which is a global measurement of the child’s
cognitive ability. Finally, the achievement scale focuses on applied skills and facts, such
as naming famous people and solving riddles.” 14 Standard K-ABC scores have a mean
score of 100 and a standard deviation of 15 and individual scores are compared to these
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values accordingly.14 Both the Fagan and K-ABC tests have known efficacy and are
widely recognized.
RESULTS
Three double blind randomized controlled trials compared the cognitive function
of infants born to mothers supplemented with varying levels of DHA throughout
pregnancy and breastfeeding to cognitive levels of children born to mothers whose
controlled supplements contained no DHA. Helland’s (2001 and 2003) control group
received corn oil and assessed child cognition at 6 and 9 months and 4 years of age
respectively, while Campoy et al’s control group received a placebo and assessed child
cognition at 6.5 years of age. The inclusion and exclusion criteria of all three studies were
similar (Table 1). All enrolled mothers were young, healthy, adults whose
supplementation began in the second trimester and continued through, at least, 3 months
of breastfeeding. Premature infants and multiple gestations were excluded because they
are more vulnerable to DHA deficiencies, as they have less time or opportunity to draw
on stores from the mom. 10,11,12
Data from all trials were reported as continuous data and could not be converted
into a dichotomous format; therefore, calculations evaluating tolerability, adverse events,
and treatment effects could not be computed. Participants in all three studies did however
receive written information and consented to participate in each trial, all of which were
approved by regional ethics committees. The women were also free to withdraw without
giving a reason, however, 43.1% and 38.7% of participants in the cod liver and corn oil
groups, respectively, from the Helland studies withdrew because of “feelings of
discomfort” the supplements gave them,11,12 and Campoy et al stated that “no illness or
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disability interfering with normal neurologic development was observed amongst its
participants.”10
Across all studies, participants also submitted pregnancy records, food frequency
questionnaires, birth records, and blood and milk sampling. No significant variations in
dietary intake, maternal age, smoking, or parental education levels existed.10,11,12
Maternal blood or milk sampling was used to evaluate the transfer of DHA from mother
to fetus and confirm higher levels in the experimental groups. 10,11,12 All trials
demonstrated this transfer, hence the validity of separating the groups into a experimental
and control population was confirmed.
In Helland et al (2001) 590 pregnant Norwegian mothers were recruited from the
National Hospital and Baerum Central Hospital in Oslo between December 1994 and
October 1996.11 They were randomized into both a control and experimental group by a
computer program and instructed to take 10mL/day of either cod liver oil (containing
DHA) or corn oil. The lack of compliance was 9.5% in the cod liver oil group and 16.1%
in the corn oil group.11 115 controls and 130 women receiving DHA completed the
intervention through the third month after delivery and allowed the cognitive Fagan test
to be performed on their children at both 6 and 9 months of age.11
In this particular version of the exam, the infants received the same 10 novelty
problems on both occasions; all problems involved comparison of familiar and new
digitized faces on a computer monitor.11 Scores were computed as above described in the
methods section; A 2-tailed student t-test was used to examine differences between the
control and experimental groups, based on mean scores and standard deviations; a p value
of <0.05 was considered significant. 11 “No significant differences in novelty preference
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between the cod and corn oil groups at either 6 or 9 months of age were found” (55.2[4.5]
vs. 55.4[3.7]% and 55.5[3.8] vs. 56.2[3.5]% respectively). 11
Table 2: Treatment v. Control Fagan Test Data at 6 and 9 months of age, Mean[SD]

Children born to mother’s
supplemented with cod liver
oil containing DHA
(N=130)
Children born to mother’s
supplemented with corn oil
lacking DHA (N=115)

6 months

9 months

55.2[4.5]

56.2[3.5]

55.4[3.7]

56.2[3.5]

In Helland et al (2003), the same children, born to mothers in the very population
above described, were followed up with at 4 years of age. 48 children born to mothers
who had taken cod liver oil and 36 children born to mothers who had taken corn oil
participated in cognition assessment via the K-ABC test. “In a backward stepwise
regression model with Mental Processing Composite as the dependent variable, maternal
intake of DHA was found to be an independent variable of clinical significance”
(r2=0.07; P=0.03).12 T-tests then measured differences between continuous variables,
and p values <0.05 were considered significant. Children in the cod liver oil group had
significantly higher MPC scores than the children in the corn oil group (106.4[7.4] v.
102.3[11.3]; P=0.049). 12
Table 3: Treatment v. Control MPC Scores at 4 Years of Age, Mean[SD]
MPC Scores from K-ABC Test
Children born to mother’s
supplemented with cod liver oil
containing DHA (N=48)
Children born to mother’s
supplemented with corn oil lacking
DHA (N=36)

106.4[7.4]
102.3[11.3]
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Campoy et al (2011) recruited healthy pregnant women, at less then 20 weeks of
gestation, from three different European antenatal care clinics. “Blockwise
randomization” was performed at each center and the women were separated into four
groups.10 For the purpose of this analysis, however, we will focus only on the groups of
women who received either supplements containing only 500 mg of DHA or a placebo
from pregnancy through 6 months of breastfeeding. Infants born to DHA supplemented
mothers who could no longer breastfeed were still allowed to remain in the study and
received either a formula containing 0.5% DHA until 6 months of age or a formula
lacking DHA.10 37 children from the DHA supplemented group and 45 children from the
control group complied with the experiment and took the K-ABC test at 6.5 years of
age.10 No compliance percentages from the mother’s were reported. The Kruskal-Walllis
test was performed to assess the effects of supplementation based on median values and
ranges obtained from K-ABC scores; p values <0.05 were considered significant. No
significant differences in the MPC scores on the K-ABC test were found between the
DHA supplemented and placebo groups (110[11] vs. 110[14.5] respectively). 10
Table 4: Treatment v. Control MPC Scores at 6.5 years of Age, Median[Range]
MPC Scores from K-ABC Test
Children born to mother’s
supplemented with cod liver oil
containing DHA (N=37)
Children born to mother’s
supplemented with a placebo (N=45)
DISCUSSION

110[11]
110[14.5]
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Using three double blind RCT’s, this meta-analysis reviewed the affects of DHA
supplementation, to pregnant and breastfeeding mothers, on the cognition of their yet
unborn children. Each article selected healthy mothers whose children were not at any
predetermined risk for cognitive deficits, however, recent studies have suggested running
similar experiments in at risk children. The validity and blinding of each RCT was
without error, however drop out rates were high, as follow up required years of
compliance, leaving the sample sizes relatively small. Furthermore, child cognition was
only assessed using two exams and many other options for evaluation exist.
DHA is a relatively safe supplement when used as directed (amounts under 3
grams per day). Its supplementation is contraindicated in patients taking blood pressure
and anticoagulant medications as it may cause pressure to drop too low and also slows
clotting.15 Under the Dietary Supplement Health and Education Act of 1994, the Food
and Drug Administration regulates DHA by requiring its manufacturers to ensure its
safety before marking and intervenes if any harmful product does reach stores.16 Since
the start of its widespread use, only minimal adverse affects, such as nausea, intestinal
gas, and bruising, have been noted. 15 No black box warnings exist. Insurances do not
cover DHA supplements yet its availability and use is widespread.
DHA supplementation has, for example, begun to be implemented in the
treatment of various disease states. In the Rotterdam studies, researches noted protective
and reductive effects of DHA on the incidence of Alzheimer’s; DHA has even been
shown to improve age related memory loss. 7 Another study measured the impact of DHA
on visual development in infants. Those who received DHA-enriched egg yolks had
greatly enhanced retina and visual cortex maturation. 7 Other less common uses include
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the treatment of Coronary Artery Disease, ADHD, and, when given along with EPA,
Psoriasis.7
CONCLUSION
The supplementation of N-3 fatty acids containing DHA, to pregnant and breast
feeding mothers, has shown inconclusive affects on child cognition. Helland et al (2003)
was the only RCT that detected a significant difference in cognitive scores between
experimental and control groups. Noting that this is the same population a previous trial
tested (at an earlier age using a different cognitive assessment) with insignificant results,
DHA supplementation’s effects remain conflicting at best.
The administration of DHA in all studies relied solely on the mother’s compliance
and honest reporting of intake. In the future, the reliability of such intake should be
standardized and controlled. The known correlation between DHA and brain structure
warrants future investigation on this matter. Continuing research should consider
enhancing the dose of DHA supplementation, testing children at later stages of life, and
even implementing new tests to assess cognition, as this matter will continue to be of
great importance in the coming years.
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